Growth Metrics

Ligand Pharmaceuticals (LGND) Assets Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Ligand Pharmaceuticals 4.61 Bn 3.83 Bn 48.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 69.21%
Dec 31, 2025 65.71%
Sep 30, 2025 54.66%
Jun 30, 2025 9.49%
Mar 31, 2025 -0.92%
Dec 31, 2024 19.63%
Sep 30, 2024 24.13%
Jun 30, 2024 14.29%
Mar 31, 2024 12.67%
Dec 31, 2023 3.22%
Sep 30, 2023 -26.78%
Jun 30, 2023 -29.56%
Mar 31, 2023 -26.61%
Dec 31, 2022 -41.22%
Sep 30, 2022 -17.51%
Jun 30, 2022 -14.33%
Mar 31, 2022 -14.67%
Dec 31, 2021 -4.75%
Sep 30, 2021 2.10%
Jun 30, 2021 1.07%
Mar 31, 2021 9.21%
Dec 31, 2020 -8.87%
Sep 30, 2020 -19.39%
Jun 30, 2020 -31.02%
Mar 31, 2020 -38.04%
Dec 31, 2019 18.57%
Sep 30, 2019 -26.51%
Jun 30, 2019 -3.04%
Mar 31, 2019 153.62%
Dec 31, 2018 87.89%
Sep 30, 2018 217.93%
Jun 30, 2018 190.35%
Mar 31, 2018 19.84%
Dec 31, 2017 11.54%
Jun 30, 2017 3.77%
Mar 31, 2017 2.65%
Dec 31, 2016 19.58%
Jun 30, 2016 102.39%
Mar 31, 2016 133.05%
Dec 31, 2015 94.96%
Sep 30, 2015 91.60%
Jun 30, 2015 205.23%
Mar 31, 2015 149.57%
Dec 31, 2014 146.42%
Sep 30, 2014 167.79%
Jun 30, 2014 0.28%
Mar 31, 2014 7.23%
Dec 31, 2013 0.43%
Sep 30, 2013 4.28%
Mar 31, 2013 -12.02%
Dec 31, 2012 -13.54%
Sep 30, 2012 -20.83%
Dec 31, 2011 59.59%